SCHEMBL5565783

SCHEMBL5565783

Nc1cccc(-c2cc3c(Nc4cccc(Oc5ccccc5)c4)ncnc3[nH]2)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EIF2AK2 P19525 1/20 0.58
GSK3B P49841 1/20 0.58
BRAF P15056 7/20 0.55
TNNI3K Q59H18 7/20 0.55
TTBK1 Q5TCY1 4/20 0.46
TTBK2 Q6IQ55 3/20 0.46
AHR P35869 1/20 0.46
EGFR P00533 3/20 0.45
KDR P35968 3/20 0.44
DYRK3 O43781 1/20 0.44
MAP4K4 O95819 1/20 0.44
PDGFRA P16234 1/20 0.44
LTK P29376 1/20 0.44
GRK5 P34947 1/20 0.44
MAPK8 P45983 1/20 0.44
CDK8 P49336 1/20 0.44
CDK7 P50613 1/20 0.44
IRAK1 P51617 1/20 0.44
NEK4 P51957 1/20 0.44
LIMK1 P53667 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8259230 0.87 BRAF (0.58) EIF2AK2GSK3BBRAFTNNI3KAHR
SCHEMBL8256959 0.82 EIF2AK2 (0.62) EIF2AK2GSK3BBRAFTNNI3KTTBK1
SCHEMBL4773624 0.82 EGFR (0.59) BRAFTNNI3KTTBK1TTBK2EGFR
SCHEMBL20139118 0.81 EGFR (0.64) BRAFTNNI3KEGFR
SCHEMBL8255837 0.80 CSNK2A2 (0.56) BRAFTNNI3KEGFRNPC1RAB9A
SCHEMBL5559435 0.79 BRAF (0.51) EIF2AK2GSK3BBRAFTNNI3KAHR
SCHEMBL8257175 0.78 EIF2AK2 (0.57) EIF2AK2GSK3BBRAFTNNI3KTTBK1
SCHEMBL8256956 0.78 BRAF (0.58) EIF2AK2GSK3BBRAFTNNI3KTTBK1
SCHEMBL8255818 0.78 EGFR (0.58) EIF2AK2GSK3BBRAFTNNI3KAHR
SCHEMBL8259233 0.77 ABCG2 (0.57) EIF2AK2GSK3BBRAFTNNI3KEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050038049-A1 Compounds that induce neuronal differentiation in embryonic stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2005-02-17 US claimed
WO-2004093812-A2 COMPOUNDS THAT INDUCE NEURONAL DIFFERENTIATION IN EMBRYONIC STEM CELLS IRM LLC (BM) 2004-11-04 WO claimed
US-7253166-B2 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells IRM LLC (BM) 2007-08-07 US disclosed
US-7253166-B2 6-phenyl-7H-pyrrolo[2,3-d]pyrimidine compounds that induce neuronal differentiation in embryonic stem cells IRM LLC (BM) 2007-08-07 US disclosed
US-20050038049-A1 Compounds that induce neuronal differentiation in embryonic stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2005-02-17 US disclosed
US-20050038049-A1 Compounds that induce neuronal differentiation in embryonic stem cells THE SCRIPPS RESEARCH INSTITUTE (US) 2005-02-17 US disclosed
WO-2004093812-A2 COMPOUNDS THAT INDUCE NEURONAL DIFFERENTIATION IN EMBRYONIC STEM CELLS IRM LLC (BM) 2004-11-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050038049-A1 Compounds that induce neuronal differentiation in embryonic stem cells FER, ERBB3, FLT3 EIF2AK2 2201/4885GSK3B 6/4885BRAF 57/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.